Powder vials
Store at −20 °C (−4 °F) in dry, dark conditions and keep them in the original packaging.

The GLOW example is a 12 or 15 unit draw once daily for 10 to 12 weeks, using a 70 mg vial mixed with 3 mL of water. A 12-unit draw holds 400 mcg each of BPC-157 and the TB component plus 2 mg of GHK-Cu. A 15-unit draw holds 500 mcg of each plus 2.5 mg of GHK-Cu.
The amounts in this chart come from online communities. The vial label shows the total peptide in milligrams (mg). The Amount column shows a portion of that total in micrograms (mcg). The syringe mark shows how much liquid corresponds to that amount.
Syringe marks below are based on a 70 mg vial with 3 mL of water added. Change vial size or water in the calculator
| Reported | Amount | Volume | Syringe mark (U-100) | Draws per vial |
|---|
Convert your vial to mcg, because 1 mg is the same as 1,000 mcg.
Divide by your water to see how much is in 1 mL.
Find what one unit holds. A U-100 syringe has 100 units in 1 mL.
Divide your amount by what one unit holds.
These numbers apply to a vial holding 50 mg of GHK-Cu, 10 mg of BPC-157, and 10 mg of the TB component, mixed to 3 mL. A different formula or a different water amount changes every number on this page.
0.12 mL, which is 400 mcg of BPC-157, 400 mcg of the TB component, and 2 mg of GHK-Cu. Total blend 2.8 mg. That gives 25 draws per vial on paper.
0.15 mL, which is 500 mcg of BPC-157, 500 mcg of the TB component, and 2.5 mg of GHK-Cu. Total blend 3.5 mg. That gives 20 draws per vial on paper.
Every draw brings all three along in the same ratio. Dropping from 15 units to 12 lowers all three together. There is no way to take less BPC-157 and keep the GHK-Cu where it was.
The example is once daily for 10 to 12 weeks. That is a community schedule, not one established by a controlled human trial of this blend.
Follow one step at a time. The steps use the water amount from your calculator.
Find the mg printed on your vial and enter it in the calculator. Let a frozen vial reach room temperature first.
Clean the top of the peptide vial and the water vial with an alcohol swab. Let them dry.
Draw bacteriostatic water with a sterile syringe.
Let the water run down the inside wall of the vial. This helps prevent foaming.
Roll the vial until the powder fully dissolves. Do not shake it hard.
Write today's date on the vial and refrigerate it at 2–8 °C (35.6–46.4 °F), away from light.

Pick how many weeks you will run it and how many shots you take each week. The list below shows everything you need.
Store at −20 °C (−4 °F) in dry, dark conditions and keep them in the original packaging.
Keep them refrigerated and away from light. How long a mixed vial lasts depends on the product, so check its stability data.
GLOW puts GHK-Cu, BPC-157, and a TB component in one vial. The example formula on this page is 50 mg of GHK-Cu, 10 mg of BPC-157, and 10 mg of TB-500, which comes to 70 mg in total.
The formula matters more than it does with a single peptide. A draw measured in syringe units tells you a volume, not how much of each peptide you just pulled. Blend names are not a specification either, so check the actual vial label and the batch documentation before you run any of these numbers.
This is the reason GHK-Cu is in the blend, and it is the largest component by far.
BPC-157 and the TB component are the pair people already run together for recovery. GLOW bundles them with the copper peptide.
The practical draw is one vial and one measurement instead of three. The trade is that you lose the ability to adjust any one component.
No controlled human study of this three-component blend was identified in the sources reviewed for this guide, so there is no measured timeline to give you. Anything you read comes from reports, not from trial data.
Pick a topic to see what has been studied.
No controlled human study of this exact 50 / 10 / 10 mg blend was identified among the sources reviewed for this guide. That is a limit of the review rather than proof that none exists, but it means the research below is about components, not about GLOW.
A 1993 rat wound-chamber study found more collagen and other extracellular matrix material accumulating. It tested GHK-Cu locally in that model, not this blend.
A 2003 rat Achilles tendon study reported better repair measures after the tendon was cut. The species, the route, and the study amounts cannot be read across as an established human GLOW protocol.
A 1999 rat wound study reported changes in wound closure and tissue repair. What was tested there was thymosin beta-4 itself, and those results should not be assigned to a shorter fragment or to a blend.
Full-length thymosin beta-4 and the shorter fragment called TB-500 are different substances. A trade name on a label does not establish which sequence is in the vial, and findings for one form do not automatically carry to the other.

Quality varies a lot between sellers. I have been around research peptides for 10 years, and BioEdge is the supplier I send my readers to. Here is why.
The Peptide Report has a business relationship with BioEdge Research Labs. BioEdge sells this product for laboratory research only. BioEdge shipping policy
GLOW is already a blend, so the comparison people want is against the blend that adds a fourth component.
| Stack | Ingredients | Why people stack them |
|---|---|---|
| GLOWOne vial, 70 mg | IngredientsGHK-Cu 50 mg, BPC-157 10 mg, and the TB component 10 mg | Skin, collagen, and tissueGHK-Cu is 71 percent of the labeled amount, which is what separates GLOW from a plain BPC-157 and TB-500 pairing. That is the component studied for collagen and extracellular matrix. |
| KLOWOne vial, 80 mg | IngredientsThe same three plus KPV 10 mg | Adds inflammatory signalingKLOW adds 10 mg of KPV to the same formula. At 15 units both hold 500 mcg of BPC-157, 500 mcg of the TB component, and 2.5 mg of GHK-Cu. KLOW also holds 500 mcg of KPV, so its total per draw is 4 mg against GLOW's 3.5 mg. That is an arithmetic difference, not evidence that one works better. See the KLOW dosage guide. |
Pick a tool and try it. Each one uses the numbers from your calculator.
Use the same four steps. Once you can solve these, you can work out the units for any vial you ever pick up.
Your score: 0 correct.
Each line on the syringe is a unit of liquid. A unit measures volume, so the amount of peptide in it depends on your mix.
Tap the syringe or move the slider. The numbers use the vial you entered above. Read the line at the top edge of the plunger.
More water makes the mix weaker, so the same amount takes up more units. The amount of peptide in the vial stays the same.
A draw under 5 units is harder to read accurately. Tap a row to use that water amount.
The example is a 12 or 15 unit draw once daily for 10 to 12 weeks, from a 70 mg vial mixed with 3 mL of water. At 12 units that is 400 mcg each of BPC-157 and the TB component plus 2 mg of GHK-Cu. At 15 units it is 500 mcg of each plus 2.5 mg of GHK-Cu.
0.15 mL holding 500 mcg of BPC-157, 500 mcg of the TB component, 2.5 mg of GHK-Cu, and 3.5 mg of blend in total.
3 mL is the amount these calculations assume. That makes 23.33 mg of blend per mL. Change the water and every number on this page changes.
25 at 12 units, or 20 at 15 units. Those are theoretical counts. Some solution stays behind in the vial and the syringe, so the real number can be lower.
KLOW adds 10 mg of KPV to the same three components, so it totals 80 mg instead of 70 mg. Mixed at the same 3 mL, the shared components come out identical per draw. KLOW just carries the KPV along as well.
No. Every draw carries all three components in the same ratio. A smaller draw lowers all of them together.
This is worth pinning down before you run numbers. 500 mcg of one ingredient and 500 mcg of the total blend are very different amounts. At 15 units you get 500 mcg of BPC-157 but 3.5 mg of blend.
Most charts assume one vial size and one water amount. If your mix is different, every unit number changes, so run your own numbers.
Instant e-Book Download